1.Effect of the chelator Zn-DTPA on the excretion of lead in lead intoxication mice detected with ICP-MS.
Chen LI ; Kaizhi LU ; Qi ZHOU ; Qiong WANG ; Yuliang ZENG ; Hongjun YIN ; Xuanhui HE ; Ying TIAN ; Junxing DONG
Acta Pharmaceutica Sinica 2014;49(11):1588-92
To study the lead excretion effect of the chelator Zn-DTPA on the lead intoxication mice, inductively coupled plasma mass spectrometry (ICP-MS) was applied to detect the lead content of biological samples. The acute lead intoxication mice model was established by injecting lead acetate intraperitoneally with the dose of 1 mg. Zn-DTPA was administered intraperitoneally to mice once daily for five consecutive days 4 h after intoxication. Control group, model group, combination of Zn-DTPA and Ca-DTPA group were evaluated at the same time. The urine was collected every day. The mice were sacrificed in batches in the 2rd, 4th, 6th day. Biological samples including urine, whole blood, femur and brain were prepared and nitrated. Lead concentration was detected by ICP-MS. The result showed that Zn-DTPA could increase lead content in urine markedly and reduce lead content in blood, femur and brain.
2.Protective effect and mechanism of IPQDS on acute myocardial infarction in rats.
Xuanhui WANG ; Xiaofeng YU ; Shaochun QU ; Huali XU ; Dong HAN ; Dayun SUI
China Journal of Chinese Materia Medica 2009;34(24):3281-3285
OBJECTIVETo observe the protective effect of Injection of Panax quinquefolium diolsaponins (IPQDS) and its mechanism on acute myocardial infarction in rats.
METHODThe acute myocardial infarct model was prepared by left anterior descending coronary occulusion for 24 hours in open chest anesthetized rats. The myocardial infarct size (MIS) was calculated. The activities of serum creatine hosphokinase (CK), lactate dehydrogenase (LDH), aspartate aminotransferase (AST), superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px), and the contents of malondialdehyde (MDA) and nitric oxide (NO) were determined. Blood was collected to observe low shearing specific viscosity, middle shearing specific viscosity and high shearing specific viscosity of whole blood and plasma viscosity. At the same time, the platelet aggregation rate and platelet adherence rate were also determined.
RESULTIn rats treated by IPQDS (in a dosage of 12.5, 25 and 50 mg x kg(-1) d, i.p. 3d ), the MIS was significantly reduced. The activities of serum CK, LDH and AST, and the content of serum MDA were declined. The activities of SOD and GSH-Px, and the content of NO were increased markedly. In addition, low shearing specific viscosity, middle shearing specific viscosity and high shearing specific viscosity of whole blood and plasma viscosity as well as platelet aggregation rate were also declined significantly. But platelet adherence rate had no significant change.
CONCLUSIONIPQDS has a protective effect on acute myocardial ischemia, which may be related to increasing activity of antioxidase in body, scavenging the damage of peroxidation from oxygen free radicals, decreasing the viscosity of blood and plasma and preventting thrombosis etc.
Animals ; Aspartate Aminotransferases ; metabolism ; Creatine Kinase ; metabolism ; Drugs, Chinese Herbal ; therapeutic use ; Female ; L-Lactate Dehydrogenase ; metabolism ; Male ; Malondialdehyde ; metabolism ; Myocardial Infarction ; drug therapy ; metabolism ; Nitric Oxide ; metabolism ; Rats ; Rats, Wistar ; Saponins ; therapeutic use ; Superoxide Dismutase ; metabolism
3.Price and affordability analysis of non-free anti-HIV drugs and therapeutic regimen in China
China Pharmacy 2022;33(21):2638-2642
OBJECTIVE To provide suggestions and references for promoting the economic efficiency of anti -AIDS drug use in China .METHODS According to the Chinese Guidelines for the Diagnosis and Treatment of AIDS (2021 Edition)and the National Free HIV Antiretroviral Drug Treatment Manual (4th Edition ),non-free anti -HIV drugs and therapeutic regimens were screened;the data on domestic and foreign drug prices were collected ,and the price and affordability of non -free anti -HIV drugs and drug regimens were analyzed with the median price ratio (MPR)method and drug affordability study method by standard survey method . RESULTS A total of 18 non-free anti -HIV drugs (based on drug names )were screened ,of which 5 drugs were only domestically produced ,11 were only imported ,and 2 were both domestic and imported drugs ;eight types were listed in the Basic Medical Insurance Catalogue (2021 Edition). The median MPR for 18 drugs was 0.504,and drugs with affordability of less than 1 accounted for 55% of the total number of drugs before medicare reimbursement ,and this figure increased to 75% after medicare reimbursement . The median affordability after reimbursement of 10 single-tablet combinations was 0.625,of which the affordability of the four single -tablet combinations recommended by the guidelines for use alone was less than 1. There was no statistically significant difference in the affordability of two regimens before and after medicare reimbursement and between recommended regimens and alternatives after reimbursement (P>0.05). CONCLUSIONS The affordability of single non -free anti - HIV drugs in China is good ,but the affordability of combination drugs is poor . The affordability advantages of single -tablet combination formulations over conventional therapeutic regimens are significant . The government and enterprises should focus on the research and development of innovative drugs and strengthen drug price control ,and establish and improve the non -free drug protection system for HIV/AIDS groups ,so that they can choose more drugs and use drugs more economically .
4.Cost-utility analysis of pembrolizumab combined with chemotherapy in the first-line treatment of advanced or unresectable biliary tract carcinoma
Ying DING ; Xuanhui WANG ; Chunbo GONG
China Pharmacy 2023;34(23):2891-2895
OBJECTIVE To evaluate the cost-effectiveness of pembrolizumab combined with chemotherapy versus placebo combined with chemotherapy in the first-line treatment of advanced or unresectable biliary tract carcinoma (BTC) from the perspective of China’s health system. METHODS A partitioned survival model was constructed based on the KEYNOTE-966 study data. The simulation period was 21 days, and the simulation time was the patient’s whole life. Using quality-adjusted life year (QALY) as the output indicator, the cost-utility analysis method was used to evaluate the cost-effectiveness of the two schemes mentioned above. Univariate and probabilistic sensitivity analyses were performed to verify the results of the basic analysis, and to explore the cost-effectiveness under the scenario of drug donation scheme. RESULTS The basic analysis showed that both the cost and effectiveness of the pembrolizumab group were higher than those of the placebo group, and the incremental cost-effectiveness ratio (ICER) was 3 909 359.78 yuan/QALY, which was higher than the willingness-to-pay (WTP) threshold of 3 times 2022 gross domestic product (GDP) per capita (257 094 yuan), indicating no cost-effectiveness. The results of univariate sensitivity analysis showed that the utility discount rate, the utility value of progression-free survival (PFS) status, the cost discount rate, and the cost of pembrolizumab had a great influence on ICER. Probabilistic sensitivity analysis verified the robustness of the results of basic analysis, and concluded that when the WTP threshold was greater than 1 500 000 yuan/QALY, the pembrolizumab group became cost-effective. The results of the scenario analysis showed that considering the drug donation scheme of pembrolizumab for low-income people, although its treatment cost was significantly reduced, it was still not cost-effective. CONCLUSIONS At the WTP threshold of 3 times China’s GDP per capita in 2022, pembrolizumab combined with chemotherapy is not cost-effective compared with placebo combined with chemotherapy for advanced or unresectable BTC.
5.Relationship between hypoadiponectinemia and hypertension in young individuals with normal renal function: Hanzhong adolescent hypertension study
Xuanhui GUO ; Chao CHU ; Qiong MA ; Yueyuan LIAO ; Yu YAN ; Yue YUAN ; Jiawen HU ; Yang WANG ; Ruihai YANG ; Jianjun MU
Journal of Xi'an Jiaotong University(Medical Sciences) 2022;43(4):594-599
【Objective】 To explore the relationship between plasma adiponectin levels and hypertension based on the Hanzhong adolescent hypertension cohort. 【Methods】 A total of 361 young individuals with normal renal function, aged 32 to 41 years old, were taken as the research subjects. We collected or measured data including general characteristics, blood pressure (BP), height, weight, pulse rate, and biochemistry indexes such as fasting glucose, blood lipid and plasma hs-CRP. The concentration of plasma adiponectin was determined by ELISA method. Binary logistic regression was performed to analyze the relationship between plasma adiponectin and hypertension. 【Results】 The plasma adiponectin level in patients with hypertension was significantly lower than that in normotensive patients [3.56 (2.57-5.02)) μg/mL vs. 4.82 (3.19-6.89) μg/mL, P=0.012]. Partial correlation analysis showed a weak correlation of plasma adiponectin level with systolic BP and diastolic BP (r=-0.155, P=0.003 and r=-0.144, P=0.006). Binary logistic regression analysis showed that after adjusting for confounding factors such as age, BMI, and high-sensitivity C-reactive protein, the risk of hypertension was 2.46 times higher in patients with plasma adiponectin in the lowest gender-specific tertile than those in the highest tertile (OR=2.46, 95% CI: 1.22-4.99). 【Conclusion】 Hypoaponectinemia is an independent risk factor for hypertension in young individuals with normal renal function.